Dan Polen - Polen Capital Management
Holding/activity history for Protagonist Therapeutics Inc. (PTGX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 24,337 | 0.02 | Add 19.60% | <0.01 | $105.40 | $2,565,120 | SEC |
| 2025 Q4 | 20,349 | 0.01 | Add 0.12% | $87.34 | $1,777,282 | SEC | |
| 2025 Q3 | 20,325 | <0.01 | Add 27.04% | <0.01 | $66.43 | $1,350,190 | SEC |
| 2025 Q2 | 15,999 | <0.01 | Buy | <0.01 | $55.27 | $884,265 | SEC |